Anxiety ,Stress, and Depression


Psychosomatic Medication Conference focusses on Functional somatic syndromes with depression and anxiety are of moderate magnitude but were highly significant statistically as when compared with a healthy person and which controls with medical disorders of known organic pathology. So it is very important to evaluate the medical causes where anxiety is accompanied by disproportionate physical symptoms like Tachycardia or atypical physical symptom like confusion. The main psychosomatic therapy which is known as Cognitive behavioral therapy (CBT) should be concerned as a first-line treatment for situational anxiety and also anxiety disorders. The use of Benzodiazepines which can help to improve primary anxiety in a short term and Tricyclic Antidepressants like Mirtazapine was also considered. Selective serotonin reuptake inhibitors, selective norepinephrine reuptake inhibitors were also used in psychosomatic therapies.


    Related Conference of Anxiety ,Stress, and Depression

    September 22-23, 2025

    6th Annual Congress on Psychiatry

    Paris, France
    October 27-28, 2025

    39th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    November 10-11, 2025

    International Congress on Cognitive Psychotherapy

    Vancouver, Canada
    November 10-11, 2025

    5th Annual Psychiatrists and Psychologists Meet

    Vancouver, Canada
    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France
    February 16-17, 2026

    6th Annual Congress on Mental Health

    Paris, France
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France

    Anxiety ,Stress, and Depression Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in